Alaska Oncology and Hematology

What Alaska Oncology and Hematology does

Alaska Oncology and Hematology, LLC is a private, physician-owned medical practice headquartered at 2925 Debarr Road in Anchorage, Alaska, that provides comprehensive oncology and hematology care to adult cancer patients throughout the state. The practice has operated for over 30 years and is staffed by two board-certified oncologists (Dr. Max Rabinowitz and Dr. Steven Liu), four physician assistants, and a management team including a research director, nurse manager, administrator, and reimbursement manager.

The practice offers diagnosis, staging, and treatment across at least eight major cancer types — breast, lung, colon, leukemia, prostate, renal, multiple myeloma, and lymphoma — using a precision medicine approach that combines advanced diagnostics (biopsies, CT/MRI/PET imaging, molecular testing such as Oncotype DX, cytogenetic testing, immunophenotyping, and FISH/PCR/karyotyping) with multimodal therapy including chemotherapy, targeted therapy (e.g., trastuzumab, pertuzumab, osimertinib, lorlatinib, PARP inhibitors), and immunotherapy (checkpoint inhibitors such as nivolumab and pembrolizumab, plus bispecific antibodies). Patient-facing services include a Kaiku Health portal, prescription refill management, online bill pay via Pos Corp, and a research program directed by Dr. Liu providing access to clinical trials through a partnership with Sarah Cannon Cancer Center. The practice also integrates Natera's Signatera circulating tumor DNA test for residual disease monitoring and partners with Alaska Regional Hospital for genetic cancer risk counseling.

The business model is a fee-for-service medical practice: revenue is generated from professional oncology and hematology services billed to insurance providers and patients, with oncology drug infusion economics providing a meaningful margin component typical of community oncology. The go-to-market is sales-led through physician referrals, self-referrals, community partnerships (American Cancer Society, Leukemia & Lymphoma Society, CancerCare, Anchorage Project Access), and a content-marketing website with patient testimonials. Geographic differentiation is the core competitive logic — patients in Alaska can receive advanced cancer care locally without traveling Outside.

Name

Alaska Oncology and Hematology

Legal name

Alaska Oncology and Hematology, LLC

Website

https://alaskaoncology.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Alaska Oncology and Hematology is a private, Anchorage-based oncology and hematology practice providing precision-medicine cancer diagnosis and treatment to adult patients across Alaska, staffed by two oncologists and four physician assistants and supported by clinical trial access through Sarah Cannon.

Ownership category

akta.pro rank

Product category

Oncology and Hematology Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industries

Breast Oncology (HLAKAFAJ), Thoracic (Lung) Oncology (HLAKAFAL)

Keywords

• Oncology medical services
• Hematology treatments
• Cancer care
• Precision oncology
• Immunotherapy services

Headquarters

HQ city

Anchorage

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Services Revenue: Revenue generated from providing oncology and hematology medical services including consultations, diagnostics, chemotherapy, targeted therapy, immunotherapy, and ongoing cancer treatment and monitoring. Services are billed to insurance providers and patients.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Alaska Oncology and Hematology is a private medical practice in Anchorage, Alaska that diagnoses and treats cancer and blood disorders. The practice provides comprehensive oncology and hematology care for breast, lung, colon, leukemia, prostate, renal, multiple myeloma, lymphoma, and melanoma, using precision medicine, chemotherapy, targeted therapy, immunotherapy, hormone therapy, and clinical trial access. Services are delivered through board-certified oncologists, physician assistants, and a research director, supported by an in-house Kaiku Health patient portal and online bill pay.

Product overview

Alaska Oncology and Hematology is a single-location oncology and hematology practice in Anchorage, Alaska providing comprehensive cancer care services. The practice offers a unified care model combining cancer diagnosis, treatment, and supportive services. Core offerings include specialized treatment programs for multiple cancer types (breast, lung, colon, leukemia, prostate, renal, multiple myeloma, lymphoma, melanoma, and others) using surgery, chemotherapy, hormone therapy, targeted therapy, and immunotherapy. The practice also provides patient-facing digital services including a Kaiku Health patient portal for health record access and communication, prescription refill management, and online bill payment. Patient support resources connect individuals to external organizations for financial assistance, genetic counseling, and community support.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Diagnosis and Treatment Services Comprehensive oncology and hematology care providing diagnosis, staging, and treatment planning for multiple cancer types including breast, lung, colon, leukemia, prostate, renal, multiple myeloma, lymphoma, melanoma, and others.
• Breast Cancer Care Specialized treatment including surgery, targeted therapy (trastuzumab, pertuzumab, Kadcyla, Enhertu), and hormone therapy (tamoxifen, aromatase inhibitors) with HER2 status and hormone receptor testing for breast cancer patients.
• Lung Cancer Treatment Evidence-based care including targeted therapies for EGFR mutations (osimertinib, amivantamab) and ALK rearrangements (lorlatinib), plus immunotherapy options (durvalumab) for lung cancer patients.
• Colon Cancer Care Expert colon cancer care including molecular testing, surgery (laparoscopic), adjuvant chemotherapy (FOLFOX regimen), and biomarker-driven targeted therapies.
• Leukemia Treatment Specialized care for acute and chronic leukemias including ALL, AML, CLL, and CML using induction/consolidation chemotherapy, stem cell transplant coordination, and targeted therapies (BTK inhibitors, TKIs).
• Prostate Cancer Care Comprehensive prostate cancer management including PSA screening, active surveillance, radical prostatectomy, hormone therapy, targeted therapy (PARP inhibitors), immunotherapy, and chemotherapy.
• Renal (Kidney) Cancer Treatment Kidney cancer care including partial and radical nephrectomy, active surveillance, ablation techniques (RFA, cryoablation), and systemic therapy including immunotherapy and targeted therapy.
• Multiple Myeloma Care Personalized multiple myeloma treatment following NCCN guidelines, including quadruplet induction regimens (daratumumab, lenalidomide, bortezomib, dexamethasone), transplant, and maintenance therapy.
• Lymphoma Treatment Comprehensive lymphoma care for Hodgkin and non-Hodgkin lymphoma including chemotherapy, immunochemotherapy (R-CHOP), monoclonal antibodies (rituximab, brentuximab vedotin), targeted therapy, and bispecific antibodies (epcoritamab, mosunetuzumab).
• Clinical Trials and Research Program Research program directed by Dr. Steven Liu providing access to cutting-edge treatments and clinical trials for eligible patients.
• Patient Portal and Online Bill Pay Online patient engagement platform (Kaiku Health) for accessing health records, communicating with care team, and managing appointments, plus secure online bill payment through Pos Corp mypay.
• Prescription Refill Services Medication management service allowing patients to request prescription refills during office visits or by phone during business hours.
• Patient Support Resources Educational and support resources including links to Leukemia & Lymphoma Society, American Cancer Society, CancerCare, genetic counseling, financial assistance programs, and community support groups.

Quantifiable outcome

• Treatment plans designed to minimize debilitating side effects associated with chemotherapy while maximizing effectiveness

Named customers4 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature3 records

Partnerships

Eight partnerships are on record, tiered support, minor and core.

• Leukemia & Lymphoma SocietysupportOthersPartnership providing patient access to financial assistance programs, support services, and educational resources for blood cancer patients
• American Cancer SocietysupportOthersCollaboration providing patients with access to cancer information, support programs, and community resources
• Women LISTEN, Org.minorOthersLocal women's health organization providing support resources for cancer patients
• Sarah Cannon Cancer CentercoreStrategic or Co-development PartnerHCA Healthcare's cancer research organization providing access to clinical trials, advanced treatments, and research-based care protocols
• Alaska Regional Hospital - Genetic Cancer Risk CounselingsupportImplementation/ SI/ Consulting PartnerPartnership for genetic cancer risk assessment and counseling services for patients with family history of cancer
• CancerCare SupportsupportOthersNational cancer support organization providing counseling, support groups, education, and financial assistance
• Cancer Connection AlaskaminorOthersLocal Alaska organization providing peer support and resources for cancer patients and families
• Anchorage Project AccessminorOthersProgram providing healthcare access for uninsured and underinsured residents in Anchorage

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Peers

• New York Oncology Hematology (NYOH):

Direct peers

• OneOncology: Partnership platform for community oncology practices offering shared services, precision medicine, and clinical trials; comparable as a peer/community oncology network whose member practices operate with similar physician-owned models.
• American Oncology Network: Network of community oncology practices providing medical oncology, hematology, and ancillary services; directly comparable as a peer-driven community oncology platform with similar payer relationships and clinical trial partnerships.
• Compass Oncology: Multi-site community oncology practice in Oregon/SW Washington offering medical oncology, hematology, radiation oncology, and clinical trials; comparable physician-led community oncology model serving a defined regional market.
• Virginia Cancer Specialists: Physician-owned community oncology and hematology practice offering comprehensive cancer care, clinical trials, and precision medicine; comparable in scale, service mix, and physician-ownership model.
• Florida Cancer Specialists & Research Institute: Community-based medical oncology and hematology practice with extensive clinical trial program; comparable business model (physician-owned, multi-site, precision medicine offerings) and similar revenue mix from professional oncology services.
• Texas Oncology: Large community oncology practice operating across 200+ Texas sites; directly comparable as a multi-site physician-owned medical oncology and hematology practice delivering chemotherapy, targeted therapy, and clinical trials in a defined geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/alaska_oncology
• Facebookfacebook.com/AlaskaOncology

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alaska Oncology and Hematology